RED SESSION: SPY -1.02% | Range-bound
SESSION RECAP
Today's trading session was characterized by a pronounced range-bound pattern across major indices, with selling pressure evident throughout the day. The S&P 500 opened at $687.83, reached a high of $690.0 early in the session, and encountered increased selling pressure in the latter half, closing at $682.39, down 1.02%. The market's hesitant start saw sharp reversals particularly after midday when the indices failed to sustain an early rebound attempt. Fear was palpable, as evidenced by the sharp rise in the VIX, with a notable spike of 10.06%, signaling increased demand for protective hedges amidst uncertainty.
Significant attention was focused on IBM, which experienced a steep 13.15% decline, weighing heavily on the market sentiment. Other growth sectors, particularly Technology and Financials, showed signs of fatigue and struggled to gain traction. Conversely, defensive sectors like Consumer Staples and Healthcare provided some relief, indicating a rotational shift towards safety amid volatile conditions. Breadth was negative, with only five out of eleven sectors displaying positive movement, further reinforcing the risk-averse tone.
MARKET SCORECARD
- S&P 500 (SPY): $687.83 → $682.39 | -1.02% | Range: $680.37-$690.0 - NASDAQ (QQQ): $601.41 | -1.22% - Russell 2000 (IWM): $260.49 | -1.56% - VIX: 21.01 (+10.06%) - Volume: Normal (0.96x average)
TODAY'S WINNERS
1. ABT (+2.74% to $115.29): Gained on strong quarterly results, surpassing revenue expectations and revised guidance upward. 2. PG (+2.73% to $165.17): Rallied on bullish analyst upgrades citing robust product demand in emerging markets. 3. XOM (+2.36% to $150.76): Strong uptick following reports of upstream success in Guyana, boosting investor confidence. 4. WMT (+2.29% to $125.81): Advanced due to increased consumer spending and positive retail sector forecasts. 5. ABBV (+2.08% to $229.48): Benefit from favorable regulatory news regarding its flagship drug lineup.
TODAY'S LOSERS
1. IBM (-13.15% to $223.35): Plummeted post-earnings disappointment, with strategic pivots failing to meet investor expectations. 2. ACN (-6.58% to $201.18): Declined after issuing a cautious outlook amidst macroeconomic pressures. 3. MA (-5.77% to $496.03): Weighed down by regulatory concerns in major international markets affecting transaction forecasts. 4. MS (-4.91% to $166.8): Dropped amid reports highlighting pressure on profit margins in the current rate environment. 5. ORCL (-4.57% to $141.31): Underperformance followed entry barriers into new AI verticals announced during their investor call.
SECTOR ROTATION ANALYSIS
The defensive positioning was evident as Consumer Staples, Healthcare, and Utilities led today, signaling a flight to safety amid growing market concerns. In contrast, sectors typically associated with risk and growth, namely Financials, Consumer Discretionary, and Technology, were laggards, suggesting a constrained risk appetite within current market environments.
TECHNICAL TAKEAWAYS
- The S&P 500 tested critical support near $680 but managed to close above it, making it a key level to monitor in the next session. - NASDAQ near-term support appears to be shaping at $600, with potential resistance at $605. - Russell 2000 fell below its crucial $261 support, suggesting increased vulnerability moving forward. - The elevated VIX hints at heightened volatility, with a key resistance level around 23 to watch for further mood shifts.
LOOKING AHEAD
Traders should keep an eye on futures for overnight developments and market sentiment shifts, especially with several important economic indicators set for release. Monitoring the reaction of financials and technology stocks will be crucial in assessing whether the market is in full risk-off mode. Key earnings and geopolitical developments will likely influence the next trading day's direction.
SESSION VERDICT
Distribution day with heavy selling into the close as defensive sectors provided limited relief.
This edition was published to members after the close on Monday, February 23, 2026.
Get every edition the moment it's released — plus the model portfolio and regime dashboard.
Archived market commentary from Assets Bulletin, an independent financial publication. Informational only — not investment advice.